Skip to main content
SpringerLink
Log in

MKT+: Ein innovativer Ansatz

  • Chapter
  • First Online:
MKT+

Part of the book series: Psychotherapie: Manuale ((PSMA))

  • 1370 Accesses

Zusammenfassung

Was ist das Individualisierte Metakognitive Therapieprogramm (MKT+)? Was sind Denkverzerrungen und Metakognitionen? Wieso wurde das MKT+ entwickelt und für welche Patientengruppe eignet es sich? Wie ist das Manual aufgebaut und was zeichnet es im Speziellen aus? Im einführenden Kapitel werden diese Fragen eingehend erörtert und erleichtern dem Therapeuten den Einstieg in das „Individualisierte Metakognitive Therapieprogramm bei Menschen mit Psychosen“.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Bechdolf, A., & Klingberg, S. (2014). Psychotherapie bei schizophrenen Störungen: Kein Evidenz-, sondern ein Implementierungsproblem. Psychiatrische Praxis, 41, 8–10.

    Article  Google Scholar 

  • Beck, K., McCutcheon, R., Stephenson, L., Schilderman, M., Patel, N., Ramsay, R., & Howes, O. D. (2019). Prevalence of treatment-resistant psychoses in the community: A naturalistic study. Journal of Psychopharmacology, 33(10), 1248–1253.

    Article  Google Scholar 

  • Bridges, J. F. P., Beusterien, K., Heres, S., Such, P., Sánchez-Covisa, J., Nylander, A.-G., Chan, E., & de Jong-Laird, A. (2018). Quantifying the treatment goals of people recently diagnosed with schizophrenia using best – worst scaling. Patient Preference and Adherence, 12, 63–70. https://doi.org/10.2147/PPA.S152870

    Article  Google Scholar 

  • Burns, A. M., Erickson, D. H., & Brenner, C. A. (2014). Cognitive-behavioral therapy for medication-resistant psychosis: A meta-analytic review. Psychiatric Services, 65, 874–880.

    Article  Google Scholar 

  • Byerly, M. J., Nakonezny, P. A., & Lescouflair, E. (2007). Antipsychotic medication adherence in schizophrenia. Psychiatric Clinics of North America, 30, 437–452.

    Article  Google Scholar 

  • Byrne, R., & Morrison, A. P. (2014). Service users’ priorities and preferences for treatment of psychosis: A user-led Delphi study. Psychiatric Services, 65, 1167–1169.

    Article  Google Scholar 

  • Chong, H. Y., Teoh, S. L., Wu, D. B.-C., Kotirum, S., Chiou, C.-F., & Chaiyakunapruk, N. (2016). Global economic burden of schizophrenia: A systematic review. Neuropsychiatric Disease and Treatment, 12, 357–373. https://doi.org/10.2147/NDT.S96649

    Article  Google Scholar 

  • Eichner, C., & Berna, F. (2016). Acceptance and efficacy of Metacognitive Training (MCT) on positive symptoms and delusions in patients with schizophrenia: A meta-analysis taking into account important moderators. Schizophrenia Bulletin, 42, 952–962.

    Article  Google Scholar 

  • Ekman, M., Granstrom, O., Omerov, S., Jacob, J., & Landen, M. (2013). The societal cost of schizophrenia in Sweden. The Journal of Mental Health Policy and Economics, 16, 13–25.

    Google Scholar 

  • Elis, O., Caponigro, J. M., & Kring, A. M. (2013). Psychosocial treatments for negative symptoms in schizophrenia: Current practices and future directions. Clinical Psychology Review, 33, 914–928.

    Article  Google Scholar 

  • Evensen, S., Wisløff, T., Lystad, J. U., Bull, H., Ueland, T., & Falkum, E. (2016). Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: A population-based study using comprehensive health and welfare registers. Schizophrenia Bulletin, 42, 476–483.

    Article  Google Scholar 

  • Gaebel, W., Hasan, A., & Falkai, P. (2019). S3-leitlinie schizophrenie. Berlin: Springer.

    Google Scholar 

  • Gillespie, A. L., Samanaite, R., Mill, J., Egerton, A., & MacCabe, J. H. (2017). Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review. BMC Psychiatry, 17(1), 12. https://doi.org/10.1186/s12888-016-1177-y

    Article  CAS  Google Scholar 

  • Görgen, W., & Engler, U. (2005). Ambulante psychotherapeutische Versorgung von psychosekranken Menschen sowie älteren Menschen in Berlin. Kammer für Psychologische Psychotherapeuten und Kinder- und Jugendlichenpsychotherapeuten im Land Berlin.

    Google Scholar 

  • Green, M. F., Horan, W. P., & Lee, J. (2019). Nonsocial and social cognition in schizophrenia: Current evidence and future directions. World Psychiatry, 18(2), 146–161.

    Article  Google Scholar 

  • Jauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014). Cognitive-behavioural therapy for the symptoms of schizophrenia: Systematic review and meta-analysis with examination of potential bias. The British Journal of Psychiatry, 204, 20–29.

    Article  CAS  Google Scholar 

  • Jauhar, S., Laws, K. R., & McKenna, P. J. (2019). CBT for schizophrenia: A critical viewpoint. Psychological Medicine, 49(8), 1233–1236.

    Article  CAS  Google Scholar 

  • Kane, J. M., Agid, O., Baldwin, M. L., Howes, O., Lindenmayer, J.-P., Marder, S., Olfson, M., Potkin, S. G., & Correll, C. U. (2019). Clinical guidance on the identification and management of treatment-resistant schizophrenia. The Journal of Psychiatry, 80(2), 18com12123.

    Google Scholar 

  • Koriat, A. (2007). Metacognition and consciousness. In P. D. Zelazo, M. Moscovitch, & E. Thompson (Hrsg.), The Cambridge handbook of consciousness (S. 289–326). Cambridge: Cambridge University Press.

    Google Scholar 

  • Kovács, G., Almási, T., Millier, A., Toumi, M., Horváth, M., Kóczián, K., Götze, Á., Kaló, Z., & Zemplényi, A. T. (2018). Direct healthcare cost of schizophrenia – European overview. European Psychiatry, 48(1), 79–92.

    Google Scholar 

  • Kühl, M., Lüdtke, T., Mehl, S., & Moritz, S. (2021). Evaluation of an Internet-based metacognitive training for individuals who hear voices. Schizophrenia Research, 228, 256–259.

    Article  Google Scholar 

  • Kuhnigk, O., Slawik, L., Meyer, J., Naber, D., & Reimer, J. (2012). Valuation and attainment of treatment goals in schizophrenia: Perspectives of patients, relatives, physicians, and payers. Journal of Psychiatric Practice, 18, 321–328.

    Article  Google Scholar 

  • Lally, J., & Gaughran, F. (2019). Treatment resistant schizophrenia – review and a call to action. Irish Journal of Psychological Medicine, 36(4), 279–291.

    Google Scholar 

  • Lau, K. C., Lee, E. H., Hui, C. L., Chang, W., Chan, S. K., & Chen, E. Y. (2015). Psychosis patients’ knowledge, adherence and attitudes towards the naming of antipsychotic medication in Hong Kong. Early Intervention in Psychiatry, 9(5), 422–427.

    Article  Google Scholar 

  • Lincoln, T. M., Suttner, C., & Nestoriuc, Y. (2008). Wirksamkeit kognitiver Interventionen in der Reduktion schizophrener Symptomatik. Eine Meta-Analyse. Psychologische Rundschau, 59, 217–232.

    Article  Google Scholar 

  • Liu, Y., Tang, C., Hung, T., Tsai, P., & Lin, M. (2018). The efficacy of Metacognitive Training for delusions in patients with schizophrenia: A meta-analysis of randomized controlled trials informs evidence-based practice. Worldviews on Evidence-Based Nursing, 15(2), 130–139. https://doi.org/10.1111/wvn.12282

    Article  Google Scholar 

  • Lutgens, D., Gariepy, G., & Malla, A. (2017). Psychological and psychosocial interventions for negative symptoms in psychosis: Systematic review and meta-analysis. The British Journal of Psychiatry, 210(5), 324–332.

    Article  Google Scholar 

  • Lynch, D., Laws, K. R., & McKenna, P. J. (2010). Cognitive behavioural therapy for major psychiatric disorder: Does it really work? A meta-analytical review of well-controlled trials. Psychological Medicine, 40, 9–24.

    Article  CAS  Google Scholar 

  • Lysaker, P. H., Dimaggio, G., Hamm, J. A., Leonhardt, B. L., Hochheiser, J., & Lysaker, J. T. (2019). Disturbances in self-experience in schizophrenia: Metacognition and the development of an integrative recovery-oriented individual psychotherapy. Psychopathology, 52(2), 135–142.

    Article  Google Scholar 

  • MacKenzie, N. E., Kowalchuk, C., Agarwal, S. M., Costa-Dookhan, K. A., Caravaggio, F., Gerretsen, P., Chintoh, A., Remington, G. J., Taylor, V. H., & Müeller, D. J. (2018). Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Frontiers in Psychiatry, 9, 622.

    Article  Google Scholar 

  • Mehl, S., Werner, D., & Lincoln, T. M. (2015). Does cognitive behavior therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Frontiers in Psychology, 6, 1450.

    Article  Google Scholar 

  • Mehl, S., Falkai, P., Berger, M., Löhr, M., Rujescu, D., Wolff, J., & Kircher, T. (2016). Leitlinienkonforme psychiatrisch-psychotherapeutische Behandlung für Patienten mit Schizophrenie. Nervenarzt, 87(3), 286–294.

    Article  CAS  Google Scholar 

  • Moritz, S., & Lysaker, P. H. (2018). Metacognition – what did James H. Flavell really say and the implications for the conceptualization and design of metacognitive interventions. Schizophrenia Research, 201, 20–26.

    Article  Google Scholar 

  • Moritz, S., Favrod, J., Andreou, C., Morrison, A. P., Bohn, F., Veckenstedt, R., Tonn, P., & Karow, A. (2013). Beyond the usual suspects: Positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophrenia Bulletin, 39, 917–922.

    Article  Google Scholar 

  • Moritz, S., Berna, F., Jaeger, S., Westermann, S., & Nagel, M. (2017). The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. European Archives of Psychiatry and Clinical Neuroscience, 267(4), 335–339. https://doi.org/10.1007/s00406-016-0694-5

    Article  Google Scholar 

  • Mueser, K. T., & McGurk, S. R. (2004). Schizophrenia. Lancet, 363, 2063–2072.

    Article  Google Scholar 

  • Polese, D., Fornaro, M., Palermo, M., De Luca, V., & De Bartolomeis, A. (2019). Treatment-resistant to antipsychotics: A resistance to everything? Psychotherapy in treatment-resistant schizophrenia and nonaffective psychosis: A 25-year systematic review and exploratory meta-analysis. Frontiers in Psychiatry, 10, 210.

    Article  Google Scholar 

  • Puschner, B., Vauth, R., Jacobi, F., & Becker, T. (2006). Bedeutung von Psychotherapie in der Versorgung von Menschen mit schizophrenen Störungen in Deutschland. Wie evidenzbasiert ist die Praxis? Nervenarzt, 77, 1301–1309.

    Article  CAS  Google Scholar 

  • Sado, M., Inagaki, A., Koreki, A., Knapp, M., Kissane, L. A., Mimura, M., & Yoshimura, K. (2013). The cost of schizophrenia in Japan. Neuropsychiatric Disease and Treatment, 9, 787–798.

    Article  Google Scholar 

  • Sarlon, E., Heider, D., Millier, A., Azorin, J.-M., König, H.-H., Hansen, K., Angermeyer, M. C., Aballéa, S., & Toumi, M. (2012). A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC Health Services Research, 12, 269–276.

    Article  Google Scholar 

  • Sauvé, G., Lavigne, K. M., Pochiet, G., Brodeur, M. B., & Lepage, M. (2020). Efficacy of psychological interventions targeting cognitive biases in schizophrenia: A systematic review and meta-analysis. Clinical Psychology Review, 78, 101854. https://doi.org/10.1016/j.cpr.2020.101854

    Article  Google Scholar 

  • Savla, G. N., Vella, L., Armstrong, C. C., Penn, D. L., & Twamley, E. W. (2013). Deficits in domains of social cognition in schizophrenia: A meta-analysis of the empirical evidence. Schizophrenia Bulletin, 39, 979–992.

    Article  Google Scholar 

  • Schaefer, J., Giangrande, E., Weinberger, D. R., & Dickinson, D. (2013). The global cognitive impairment in schizophrenia: Consistent over decades and around the world. Schizophrenia Research, 150, 42–50.

    Article  Google Scholar 

  • Schlier, B., & Lincoln, T. M. (2016). Blinde Flecken? Der Einfluss von Stigma auf die psychotherapeutische Versorgung von Menschen mit Schizophrenie. Verhaltenstherapie, 26(4), 279–290.

    Article  Google Scholar 

  • Schlier, B., Wiese, S., Frantz, I., & Lincoln, T. M. (2017). Chancengleichheit in der ambulanten Therapie: Ein Experiment zur Bereitschaft von niedergelassenen Psychotherapeuten, Patienten mit Schizophrenie zu behandeln. Verhaltenstherapie, 27(3), 161–168.

    Article  Google Scholar 

  • Shafran, R., Clark, D. M., Fairburn, C. G., Arntz, A., Barlow, D. H., Ehlers, A., Freeston, M., Garety, P. A., Hollon, S. D., Ost, L. G., Salkovskis, P. M., Williams, J. M., & Wilson, G. T. (2009). Mind the gap: Improving the dissemination of CBT. Behaviour Research and Therapy, 47, 902–909.

    Article  CAS  Google Scholar 

  • Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. P. (2017). Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Preference and Adherence, 11, 449.

    Article  Google Scholar 

  • Velthorst, E., Koeter, M., Van Der Gaag, M., Nieman, D. H., Fett, A. K. J., Smit, F., Staring, A. B. P., Meijer, C., & De Haan, L. (2015). Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: Meta-analysis and meta-regression. Psychological Medicine, 45(3), 453.

    Article  CAS  Google Scholar 

  • Warner, R. (2009). Recovery from schizophrenia and the recovery model. Current Opinion in Psychiatry, 22, 374–380.

    Article  Google Scholar 

  • Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34, 523–537.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg, Hamburg, Deutschland

    Steffen Moritz, Francesca Bohn & Ruth Veckenstedt

  2. AWO Psychiatriezentrum, Königslutter am Elm, Deutschland

    Eva Carolin Krieger

  3. Kinder- und Jugendpsychiatrie und -psychotherapie, Universitätsklinikum Carl Gustav Carus, Dresden, Deutschland

    Julia Elmers

Authors
  1. Steffen Moritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Carolin Krieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Bohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julia Elmers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruth Veckenstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steffen Moritz .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moritz, S., Krieger, E.C., Bohn, F., Elmers, J., Veckenstedt, R. (2023). MKT+: Ein innovativer Ansatz. In: MKT+. Psychotherapie: Manuale. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64467-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-64467-6_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-64466-9

  • Online ISBN: 978-3-662-64467-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation